These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 34467765)

  • 1. Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT
    Zajdel P; Grychowska K; Mogilski S; Kurczab R; Satała G; Bugno R; Kos T; Gołębiowska J; Malikowska-Racia N; Nikiforuk A; Chaumont-Dubel S; Bantreil X; Pawłowski M; Martinez J; Subra G; Lamaty F; Marin P; Bojarski AJ; Popik P
    J Med Chem; 2021 Sep; 64(18):13279-13298. PubMed ID: 34467765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual 5-HT3 and 5-HT6 Receptor Antagonist FPPQ Normalizes Phencyclidine-Induced Disruption of Brain Oscillatory Activity in Rats.
    Castañé A; Cano M; Ruiz-Avila L; Miquel-Rio L; Celada P; Artigas F; Riga MS
    Int J Neuropsychopharmacol; 2022 May; 25(5):425-431. PubMed ID: 35022720
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Hogendorf A; Hogendorf AS; Kurczab R; Satała G; Szewczyk B; Cieślik P; Latacz G; Handzlik J; Lenda T; Kaczorowska K; Staroń J; Bugno R; Duszyńska B; Bojarski AJ
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dual-acting 5-HT
    Canale V; Grychowska K; Kurczab R; Ryng M; Keeri AR; Satała G; Olejarz-Maciej A; Koczurkiewicz P; Drop M; Blicharz K; Piska K; Pękala E; Janiszewska P; Krawczyk M; Walczak M; Chaumont-Dubel S; Bojarski AJ; Marin P; Popik P; Zajdel P
    Eur J Med Chem; 2020 Dec; 208():112765. PubMed ID: 32949963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 1H-Pyrrolo[3,2-c]quinoline Based 5-HT6 Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with Alzheimer's Disease.
    Grychowska K; Satała G; Kos T; Partyka A; Colacino E; Chaumont-Dubel S; Bantreil X; Wesołowska A; Pawłowski M; Martinez J; Marin P; Subra G; Bojarski AJ; Lamaty F; Popik P; Zajdel P
    ACS Chem Neurosci; 2016 Jul; 7(7):972-83. PubMed ID: 27100049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AVN-322 is a Safe Orally Bio-Available Potent and Highly Selective Antagonist of 5-HT6R with Demonstrated Ability to Improve Impaired Memory in Animal Models.
    Ivachtchenko AV; Ivanenkov YA; Veselov MS; Okun IM
    Curr Alzheimer Res; 2017; 14(3):268-294. PubMed ID: 27829340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual 5-HT
    Grychowska K; Chaumont-Dubel S; Kurczab R; Koczurkiewicz P; Deville C; Krawczyk M; Pietruś W; Satała G; Buda S; Piska K; Drop M; Bantreil X; Lamaty F; Pękala E; Bojarski AJ; Popik P; Marin P; Zajdel P
    ACS Chem Neurosci; 2019 Jul; 10(7):3183-3196. PubMed ID: 30896921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: a potential role for 5-HT1A receptor agonism and 5-HT3 receptor antagonism.
    du Jardin KG; Jensen JB; Sanchez C; Pehrson AL
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):160-71. PubMed ID: 23916504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.
    Kołaczkowski M; Marcinkowska M; Bucki A; Śniecikowska J; Pawłowski M; Kazek G; Siwek A; Jastrzębska-Więsek M; Partyka A; Wasik A; Wesołowska A; Mierzejewski P; Bienkowski P
    Eur J Med Chem; 2015 Mar; 92():221-35. PubMed ID: 25557493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Phenyl-1
    Drop M; Canale V; Chaumont-Dubel S; Kurczab R; Satała G; Bantreil X; Walczak M; Koczurkiewicz-Adamczyk P; Latacz G; Gwizdak A; Krawczyk M; Gołębiowska J; Grychowska K; Bojarski AJ; Nikiforuk A; Subra G; Martinez J; Pawłowski M; Popik P; Marin P; Lamaty F; Zajdel P
    ACS Chem Neurosci; 2021 Apr; 12(7):1228-1240. PubMed ID: 33705101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 5-HT
    Skovgård K; Agerskov C; Kohlmeier KA; Herrik KF
    Neuropharmacology; 2018 Dec; 143():130-142. PubMed ID: 30243914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An exit beyond the pharmacophore model for 5-HT
    Kucwaj-Brysz K; Ali W; Kurczab R; Sudoł-Tałaj S; Wilczyńska-Zawal N; Jastrzębska-Więsek M; Satała G; Mordyl B; Żesławska E; Agnieszka-Olejarz-Maciej ; Czarnota K; Latacz G; Partyka A; Wesołowska A; Nitek W; Handzlik J
    Bioorg Chem; 2022 Apr; 121():105695. PubMed ID: 35228010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin 3 receptor antagonist treatment for schizophrenia: meta-analysis and systematic review.
    Kishi T; Mukai T; Matsuda Y; Iwata N
    Neuromolecular Med; 2014 Mar; 16(1):61-9. PubMed ID: 23896722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT
    Kwan C; Huot P
    Neurodegener Dis Manag; 2019 Oct; 9(5):251-253. PubMed ID: 31580227
    [No Abstract]   [Full Text] [Related]  

  • 15. 5-HT
    Drop M; Koczurkiewicz-Adamczyk P; Bento O; Pietruś W; Satała G; Blicharz-Futera K; Canale V; Grychowska K; Bantreil X; Pękala E; Kurczab R; Bojarski AJ; Chaumont-Dubel S; Marin P; Lamaty F; Zajdel P
    Eur J Med Chem; 2024 Sep; 275():116615. PubMed ID: 38936149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of novel N
    Nirogi RV; Bandyala TR; Gangadasari PR; Khagga M
    J Enzyme Inhib Med Chem; 2016; 31(sup1):1-15. PubMed ID: 27806648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 5-hydroxytryptamine (serotonin) receptor 6 agonist EMD 386088 ameliorates ketamine-induced deficits in attentional set shifting and novel object recognition, but not in the prepulse inhibition in rats.
    Nikiforuk A; Fijał K; Potasiewicz A; Popik P; Kos T
    J Psychopharmacol; 2013 May; 27(5):469-76. PubMed ID: 23479455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piperazine analogs of naphthyridine-3-carboxamides and indole-2-carboxamides: novel 5-HT3 receptor antagonists with antidepressant-like activity.
    Dhar AK; Mahesh R; Jindal A; Bhatt S
    Arch Pharm (Weinheim); 2015 Jan; 348(1):34-45. PubMed ID: 25581677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Aminoimidazole-based antagonists of the 5-HT
    Hogendorf AS; Hogendorf A; Kurczab R; Kalinowska-Tłuścik J; Popik P; Nikiforuk A; Krawczyk M; Satała G; Lenda T; Knutelska J; Bugno R; Staroń J; Pietruś W; Matłoka M; Dubiel K; Moszczyński-Pętkowski R; Pieczykolan J; Wieczorek M; Pilarski B; Zajdel P; Bojarski AJ
    Eur J Med Chem; 2019 Oct; 179():1-15. PubMed ID: 31229883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procognitive properties of drugs with single and multitargeting H3 receptor antagonist activities.
    Nikolic K; Filipic S; Agbaba D; Stark H
    CNS Neurosci Ther; 2014 Jul; 20(7):613-23. PubMed ID: 24836924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.